Albeit survival difference did not reach statistical significance, the 11.7 month advantage in median OS with 177 Lu-DOTATE treatment might be considered clinically relevant ( 21 ).
← all excerpts
Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
1
—
—